Medical management of trigeminal neuropathic pains

Bibliography

• Cohen AS, Matharu MS, Goadsby PJ. Short-lasting unilateral neuralgiform headache attacks with conjunctival injection and tearing (SUNCT) or cranial autonomic features (SUNA) – a prospective clinical study of SUNCT and SUNA. Brain 2006;129:2746-6
   PubMed Web of Science ®Google Scholar
• Anonymous. The international classification of headache disorders: 2nd edition. Cephalalgia 2004;24(Suppl 1):9-160
   Google Scholar
• Zakrzewska JM. Diagnosis and differential diagnosis of trigeminal neuralgia. Clin J Pain 2002;18:14-21
   PubMed Web of Science ®Google Scholar
• Woolf CJ, Bennett GJ, Doherty M, Towards a mechanism-based classification of pain? Pain 1998;77:227-9
   PubMed Web of Science ®Google Scholar
• Finnerup NB, Sindrup SH, Jensen TS. Chronic neuropathic pain: mechanisms, drug targets and measurement. Fundam Clin Pharmacol 2007;21:129-36
   PubMedGoogle Scholar
• Bennett MI, Attal N, Backonja MM, Using screening tools to identify neuropathic pain. Pain 2007;127:199-203
   PubMed Web of Science ®Google Scholar
• Fisher A, Zakrzewska JM, Patsalos PN. Trigeminal neuralgia: current treatments and future developments. Expert Opin Emerg Drugs 2003;8:123-43
   PubMedGoogle Scholar
• Merskey H, Bogduk N. Classification of chronic pain. Descriptors of chronic pain syndromes and definitions of pain terms., 2nd Edition. IASP Press, Seattle, 1994
   Google Scholar
• Zakrzewska JM, Hamlyn PJ. Facial pain. In: Crombie IKCPR, Linton SJ, LeResche L, Von Korff M, editors, Epidemiology of pain, 1st Edition. IASP Press, Seattle, 1999
   Google Scholar
• Dieleman JP, Kerklaan J, Huygen FJ, Incidence rates and treatment of neuropathic pain conditions in the general population. Pain 2008;137:681-8
   PubMed Web of Science ®Google Scholar
• Hall GC, Carroll D, Parry D, McQuay HJ. Epidemiology and treatment of neuropathic pain: the UK primary care perspective. Pain 2006;122:156-62
   PubMed Web of Science ®Google Scholar
• Drangsholt M, Truelove E. Trigeminal neuralgia mistaken as temporomandibular disorder. J Evid Based Dent Pract 2001;1:41-50
   Google Scholar
• McDermott AM, Toelle TR, Rowbotham DJ, The burden of neuropathic pain: results from a cross-sectional survey. Eur J Pain 2006;10:127-35
   PubMed Web of Science ®Google Scholar
• Tolle T, Dukes E, Sadosky A. Patient burden of trigeminal neuralgia: results from a Cross-Sectional Survey of health state impairment and treatment patterns in six European Countries. Pain Pract 2006;6:153-60
   PubMedGoogle Scholar
• Breivik H, Collett B, Ventafridda V, Survey of chronic pain in Europe: prevalence, impact on daily life, and treatment. Eur J Pain 2006;10:287-333
   PubMed Web of Science ®Google Scholar
• Limonadi FM, McCartney S, Burchiel KJ. Design of an artificial neural network for diagnosis of facial pain syndromes. Stereotact Funct Neurosurg 2006;84:212-20
   Google Scholar
• Devor M, Amir R, Rappaport ZH. Pathophysiology of trigeminal neuralgia: the ignition hypothesis. Clin J Pain 2002;18:4-13
   PubMed Web of Science ®Google Scholar
• Obermann M, Yoon MS, Ese D, Impaired trigeminal nociceptive processing in patients with trigeminal neuralgia. Neurology 2007;69:835-41
   PubMed Web of Science ®Google Scholar
• Wiffen PJ, McQuay HJ, Moore RA. Carbamazepine for acute and chronic pain. Cochrane Database Syst Rev 2005;3:CD005451
   Google Scholar
• Wiffen PJ, McQuay HJ, Edwards JE, Moore RA. Gabapentin for acute and chronic pain. Cochrane Database Syst Rev 2005;3:CD005452
   PubMedGoogle Scholar
• Wiffen PJ, Rees J. Lamotrigine for acute and chronic pain. Cochrane Database Syst Rev 2007;2:CD006044
   Google Scholar
• He L, Wu B, Zhou M. Non-antiepileptic drugs for trigeminal neuralgia. Cochrane Database Syst Rev 2006;3:CD004029
   Google Scholar
• Zakrzewska JM, Linskey ME. Trigeminal neuralgia. Clin Evid 2009;1207
   Google Scholar
• Cruccu G, Gronseth G, Alksne J, AAN-EFNS guidelines on trigeminal neuralgia management. Eur J Neurol 2008;15:1013-28
   PubMed Web of Science ®Google Scholar
• Gronseth G, Cruccu G, Alksne J, Practice parameter: the diagnostic evaluation and treatment of trigeminal neuralgia (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology and the European Federation of Neurological Societies. Neurology 2008;71:1183-90
   PubMed Web of Science ®Google Scholar
• Jorns TP, Zakrzewska JM. Evidence-based approach to the medical management of trigeminal neuralgia. Br J Neurosurg 2007;21:253-61
   PubMed Web of Science ®Google Scholar
• Dworkin RH, Turk DC, Farrar JT, Core outcome measures for chronic pain clinical trials: IMMPACT recommendations. Pain 2005;113:9-19
   PubMed Web of Science ®Google Scholar
• Fromm GH, Terrence CF, Chattha AS. Baclofen in the treatment of trigeminal neuralgia: double-blind study and long-term follow-up. Ann Neurol 1984;15:240-4
   PubMed Web of Science ®Google Scholar
• Parekh S, Shah K, Kotdawalla H, Gandhi I. Baclofen in carbamazepine resistant trigeminal neuralgia – a double blind clinical trial. Cephalalgia 1989;9:392-3
   Google Scholar
• Fromm GH, Terrence CF. Comparison of L-baclofen and racemic baclofen in trigeminal neuralgia. Neurology 1987;37:1725-8
   PubMed Web of Science ®Google Scholar
• Campbell FG, Graham JG, Zilkha KJ. Clinical trial of carbamazepine (tegretol) in trigeminal neuralgia. J Neurol Neurosurg Psychiatry 1966;29:265-7
   PubMed Web of Science ®Google Scholar
• Killian JM, Fromm GH. Carbamazepine in the treatment of neuralgia. Arch Neurol 1968;19:129-36
   PubMed Web of Science ®Google Scholar
• Nicol CF. A four year double-blind study of tegretol in facial pain. Headache 1969;9:54-7
   PubMedGoogle Scholar
• Rockliff BW, Davis EH. Controlled sequential trials of carbamazepine in trigeminal neuralgia. Arch Neurol 1966;15:129-36
   PubMed Web of Science ®Google Scholar
• Devor M, Wood I, Sharav Y, Zakrzewska JM. Trigeminal neuralgia during sleep. Pain Pract 2008
   Google Scholar
• Miller AD, Krauss GL, Hamzeh FM. Improved CNS tolerability following conversion from immediate- to extended-release carbamazepine. Acta Neurol Scand 2004;109:374-7
   PubMed Web of Science ®Google Scholar
• Taylor JC, Brauer S, Espir MLE. Long-term treatment of trigeminal neuralgia. Postgrad Med J 1981;57:16-8
   PubMed Web of Science ®Google Scholar
• Sist T, Filadora V, Miner M, Lema M. Gabapentin for idiopathic trigeminal neuralgia: report of two cases. Neurology 1997;48:1467
   PubMed Web of Science ®Google Scholar
• Valzania F, Strafella AP, Nassetti SATA, Tassinari CA. Gabapentin in idiopathic trigeminal neuralgia. Neurology 1998;50(4):A379
   Google Scholar
• Cheshire WP Jr. Defining the role for gabapentin in the treatment of trigeminal neuralgia: a retrospective study. J Pain 2002;3:137-42
   PubMed Web of Science ®Google Scholar
• Serpell MG. Gabapentin in neuropathic pain syndromes: a randomised, double-blind, placebo-controlled trial. Pain 2002;99:557-66
   PubMed Web of Science ®Google Scholar
• Lemos L, Flores S, Oliveira P, Almeida A. Gabapentin supplemented with ropivacain block of trigger points improves pain control and quality of life in trigeminal neuralgia patients when compared with gabapentin alone. Clin J Pain 2008;24:64-75
   PubMed Web of Science ®Google Scholar
• Lunardi G, Leandri M, Albano C, Clinical effectiveness of lamotrigine and plasma levels in essential and symptomatic trigeminal neuralgia. Neurology 1997;48:1714-17
   PubMed Web of Science ®Google Scholar
• Canavero S, Bonicalzi V, Ferroli P, Lamotrigine control of idiopathic trigeminal neuralgia [letter]. J Neurol Neurosurg Psychiatry 1995;59:646
   PubMed Web of Science ®Google Scholar
• Zakrzewska JM, Chaudhry Z, Nurmikko TJ, Lamotrigine (lamictal) in refractory trigeminal neuralgia: results from a double-blind placebo controlled crossover trial. Pain 1997;73:223-30
   PubMed Web of Science ®Google Scholar
• Liebel JT, Menger N, Langohr H. Oxcarbazepine in der Behandlung der Trigeminusneuralgie. Nervenheilkunde 2001;20:461-5
   Google Scholar
• Beydoun A, Kutluay E. Oxcarbazepine. Expert Opin Pharmacother 2002;3:59-71
   PubMedGoogle Scholar
• Beydoun A, Schmidt D, D'souza J. Oxcarbazepine versus carbamazepine in trigeminal neuralgia : a meta-anlaysis of three double blind comparative trials. Neurology 2002;S3:2
   Google Scholar
• Zakrzewska JM, Patsalos PN. Oxcarbazepine: a new drug in the management of intractable trigeminal neuralgia. J Neurol Neurosurg Psychiatry 1989;52:472-6
   PubMed Web of Science ®Google Scholar
• Farago F. Trigeminal neuralgia: its treatment with two new carbamazepine analogues. Eur Neurol 1987;26:73-83
   PubMed Web of Science ®Google Scholar
• Remillard G. Oxcarbazepine and intractable trigeminal neuralgia. Epilepsia 1994;35:s28-9
   Web of Science ®Google Scholar
• Zakrzewska JM, Patsalos PN. Long-term cohort study comparing medical (oxcarbazepine) and surgical management of intractable trigeminal neuralgia. Pain 2002;95:259-66
   PubMed Web of Science ®Google Scholar
• Gilron I, Booher SL, Rowan MS, A randomized, controlled trial of high-dose dextromethorphan in facial neuralgias. Neurology 2000;55:964-71
   PubMed Web of Science ®Google Scholar
• Gilron I, Booher SL, Rowan JS, Max MB. Topiramate in trigeminal neuralgia: a randomized, placebo-controlled multiple crossover pilot study. Clin Neuropharmacol 2001;24:109-12
   PubMed Web of Science ®Google Scholar
• Kondziolka D, Lemley T, Kestle JR, The effect of single-application topical ophthalmic anesthesia in patients with trigeminal neuralgia. A randomized double-blind placebo-controlled trial. J Neurosurg 1994;80:993-7
   PubMed Web of Science ®Google Scholar
• Bittar GT, Graff-Radford SB. The effects of streptomycin/lidocaine block on trigeminal neuralgia: a double blind crossover placebo controlled study. Headache 1993;33:155-60
   PubMed Web of Science ®Google Scholar
• Lindstrom P, Lindblom V. The analgesic effect of tocainide in trigeminal neuralgia. Pain 1987;28:45-50
   PubMed Web of Science ®Google Scholar
• Fromm GH, Aumentado D, Terrence CF. A clinical and experimental investigation of the effects of tizanidine in trigeminal neuralgia. Pain 1993;53:265-71
   PubMed Web of Science ®Google Scholar
• Vilming ST, Lyberg T, Latase X. Tizanidine in the management of trigeminal neuralgia. Cephalalgia 1986;6:181-2
   PubMed Web of Science ®Google Scholar
• Kanai A, Saito M, Hoka S. Subcutaneous sumatriptan for refractory trigeminal neuralgia. Headache J Head Face Pain 2006;46:577-82
   PubMed Web of Science ®Google Scholar
• Iannone A, Baker AB, Morrell F. Dilantin in the treatment of trigeminal neuralgia. Neurology 1958;8:126-8
   PubMed Web of Science ®Google Scholar
• Braham J, Saia A. Phenytoin in the treatment of trigeminal and other neuralgias. Lancet 1960;2:892-3
   Web of Science ®Google Scholar
• Chinitz A, Seelinger DF, Greenhouse AH. Anticonvulsant therapy in trigeminal neuralgia. Am J Med Sci 1966;252:62-7
   PubMed Web of Science ®Google Scholar
• Peiris JB, Perera GL, Devendra SV, Lionel ND. Sodium valproate in trigeminal neuralgia treatment of tic douloureux with a new anticonvulsant (clonazepam). Med J Aust 1980;2:278-9
   PubMed Web of Science ®Google Scholar
• Caccia MR. Clonazepam in facial neuralgia and cluster headache. Clinical and electrophysiological study. Eur Neurol 1975;13:560-3
   PubMed Web of Science ®Google Scholar
• Chandra B. The use of clonazepam in the treatment of tic douloureux (a preliminary report). Proc Aust Assoc Neurol 1976;13:119-22
   PubMedGoogle Scholar
• Court JE, Kase CS. Treatment of tic douloureux with a new anticonvulsant (clonazepam). J Neurol Neurosurg Psychiatry 1976;39:297-9
   PubMed Web of Science ®Google Scholar
• Smirne S, Scarlato G. Clonazepam in cranial neuralgias. Med J Aust 1977;1:93-4
   PubMed Web of Science ®Google Scholar
• Cheshire WP. Felbamate relieved trigeminal neuralgia. Clin J Pain 1995;11:139-42
   Google Scholar
• Jorns TP, Johnston A, Zakrzewska JM. Pilot study to evaluate the efficacy and tolerability of leviteracetam (keppra) in the treatment of patients with trigemional neuralgia. Eur J Neurol 2009;16:740-4
   PubMed Web of Science ®Google Scholar
• Obermann M, Yoon MS, Sensen K, Efficacy of pregabalin in the treatment of trigeminal neuralgia. Cephalalgia 2008;28:174-81
   PubMed Web of Science ®Google Scholar
• Perez C, Navarro A, Saldana MT, Patient-reported outcomes in subjects with painful trigeminal neuralgia receiving pregabalin: evidence from medical practice in primary care settings. Cephalalgia 2009;29:781-90
   PubMedGoogle Scholar
• Fusco BM, Alessandri M. Analgesic effect of capsaicin in idiopathic trigeminal neuralgia. Anesth Analg 1992;74:375-7
   PubMed Web of Science ®Google Scholar
• Epstein JB, Marcoe JH. Topical application of capsaicin for treatment of oral neuropathic pain and trigeminal neuralgia. Oral Surg Oral Med Oral Pathol 1994;77:135-40
   PubMedGoogle Scholar
• Goebel A, Netal S, Schedel R, Sprotte G. Human pooled immunoglobulin in the treatment of chronic pain syndromes. Pain Med 2002;3:119-27
   PubMed Web of Science ®Google Scholar
• Goebel A, Moore A, Weatherall R, Intravenous immunoglobulin in the treatment of primary trigeminal neuralgia refractory to carbamazepine: a study protocol [ISRCTN33042138]. BMC Neurol 2003;3:1
   Google Scholar
• Khan OA. Gabapentin relieves trigeminal neuralgia in multiple sclerosis patients. Neurology 1998;51:611-14
   PubMed Web of Science ®Google Scholar
• Solaro C, Messmer UM, Uccelli A, Low-dose gabapentin combined with either lamotrigine or carbamazepine can be useful therapies for trigeminal neuralgia in multiple sclerosis. Eur Neurol 2000;44:45-8
   PubMed Web of Science ®Google Scholar
• DMKG study group. Misoprostol in the treatment of trigeminal neuralgia associated with multiple sclerosis. J Neurol 2003;250:542-5
   PubMed Web of Science ®Google Scholar
• Zvartau-Hind M, Din MU, Gilani A, Topiramate relieves refractory trigeminal neuralgia in MS patients. Neurology 2000;55:1587-8
   PubMed Web of Science ®Google Scholar
• Katusic S, Williams DB, Beard CM, Epidemiology and clinical features of idiopathic trigeminal neuralgia and glossopharyngeal neuralgia: similarities and differences, Rochester, Minnesota, 1945-1984. Neuroepidemiology 1991;10:276-81
   PubMed Web of Science ®Google Scholar
• Rushton JG, Stevens JC, Miller RH. Glossopharyngeal (vagoglossopharyngeal) neuralgia: a study of 217 cases. Arch Neurol 1981;38:201-5
   PubMedGoogle Scholar
• Kitchener JM. Glossopharyngeal neuralgia responding to pregabalin. Headache 2006;46:1307-8
   Google Scholar
• Titlic M, Jukic I, Tonkic A, Use of lamotrigine in glossopharyngeal neuralgia: a case report. Headache 2006;46:167-9
   Google Scholar
• Luef G, Poewe W. Oxcarbazepine in glossopharyngeal neuralgia: clinical response and effect on serum lipids. Neurology 2004;63:2447-8
   Google Scholar
• Ekbom KA, Westerberg CE. Carbamazepine in glossopharyngeal neuralgia. Arch Neurol 1966;14:595-6
   PubMedGoogle Scholar
• Moretti R, Torre P, Antonello RM, Gabapentin treatment of glossopharyngeal neuralgia: a follow-up of four years of a single case. Eur J Pain 2002;6:403-7
   Web of Science ®Google Scholar
• Forssell H, Tenovuo O, Silvoniemi P, Jaaskelainen SK. Differences and similarities between atypical facial pain and trigeminal neuropathic pain. Neurology 2007;69:1451-9
   PubMed Web of Science ®Google Scholar
• Baad-Hansen L. Atypical odontalgia – pathophysiology and clinical management. J Oral Rehabil 2008;35:1-11
   PubMed Web of Science ®Google Scholar
• List T, Leijon G, Helkimo M, Clinical findings and psychosocial factors in patients with atypical odontalgia: a case-control study. J Orofac Pain 2007;21:89-98
   PubMed Web of Science ®Google Scholar
• List T, Leijon G, Helkimo M, Effect of local anesthesia on atypical odontalgia – a randomized controlled trial. Pain 2006;122:306-14
   PubMed Web of Science ®Google Scholar
• O'Connor AB, Dworkin RH. Treatment of neuropathic pain: an overview of recent guidelines. Am J Med 2009;122:S22-32
   PubMed Web of Science ®Google Scholar
• Attal N, Cruccu G, Haanpaa M, EFNS guidelines on pharmacological treatment of neuropathic pain. Eur J Neurol 2006;13:1153-69
   PubMed Web of Science ®Google Scholar
• Moulin DE, Clark AJ, Gilron I, Pharmacological management of chronic neuropathic pain – consensus statement and guidelines from the Canadian Pain Society. Pain Res Manag 2007;12:13-21
   PubMed Web of Science ®Google Scholar
• Dworkin RH, O'Connor AB, Backonja M, Pharmacologic management of neuropathic pain: evidence-based recommendations. Pain 2007;132:237-51
   PubMed Web of Science ®Google Scholar
• Torrance N, Smith BH, Watson MC, Bennett MI. Medication and treatment use in primary care patients with chronic pain of predominantly neuropathic origin. Fam Pract 2007;24:481-5
   PubMed Web of Science ®Google Scholar
• Woda A, Grushka M. Burning mouth syndrome. In: Zakrzewska JM, editors, Orofacial Pain. 1st Edition. Oxford University Press, Oxford; 2009
   Google Scholar
• Patton LL, Siegel MA, Benoliel R, De Laat A. Management of burning mouth syndrome: systematic review and management recommendations. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2007;103(Suppl):S39-13
   Google Scholar
• Buchanan J, Zakrzewska J. Burning mouth syndrome. Clin Evid 2005;1685-90
   Google Scholar
• Zakrzewska JM, Forssell H, Glenny AM. Interventions for the treatment of burning mouth syndrome. Cochrane Database Syst Rev 2005;1:CD002779
   Google Scholar
• Zakrzewska JM. Insights : facts and stories behind trigeminal neuralgia. Gainesville: Trigeminal neuralgia association, 2006
   Google Scholar
• Katz J, Finnerup NB, Dworkin RH. Clinical trial outcome in neuropathic pain. Relationship to study characteristics. Neurology 2008;70:250-1
   Google Scholar
• Straube S, Derry S, McQuay HJ, Moore RA. Enriched enrolment: definition and effects of enrichment and dose in trials of pregabalin and gabapentin in neuropathic pain. A systematic review. Br J Clin Pharmacol 2008;66:266-75
   PubMed Web of Science ®Google Scholar